IMMP Immutep Ltd: Company Value to Revenue

Public company logo of Immutep (IMMP)

Immutep Limited is optimizing expenses by utilizing external CDMO facilities for protein synthesis instead of maintaining its own bioreactors. The price-to-sales ratio trend clearly demonstrates market confidence in management, while the -2171.49 value confirms the current level. Therapy development is accelerating through AI modeling, and the success of molecules for breast cancer treatment is attracting the attention of global pharma behemoths.

IMMP Immutep Ltd Company Value to Revenue (11/23/2025 - 11/20/2026)

IMMP (Immutep): analytical breakdowns and indicator data

- market value and analyst target forecast:
Fundamental valuation:immutep.com IMMP
Core merchandise of immutep.com

This indicator determines the total enterprise value minus net debt relative to annual sales volume. By analyzing the enterprise value-to-revenue trend, an investor assesses the actual overpayment for assets excluding leverage. The metric identifies abnormal price stability, signaling potential artificial price suppression. For Immutep Limited (IMMP), such a calculation is critical, as the absence of stable cash flows makes the valuation dependent on external financing. This highlights volatility risks when seeking new capital.